Cardiovascular medication trials were almost all positive before 2000, then almost all negative after 2000 — not because medicine changed, but because a funding agency required pre-registered predictions, eliminating post-hoc data fishing.
Snapshot · Modern Wisdom
Cardiovascular medication trials were almost all positive before 2000, then almost all negative after 2000 — not because medicine changed, but because a funding agency required pre-registered predictions, eliminating post-hoc data fishing.
Where this was said
At 31:10 · chapter starts 29:33
Epstein pivots to a chapter of his book on the replication crisis in science, framing it explicitly as a failure of constraints on how researchers are allowed to reason from data [1] — David Epstein "Most published research is wrong because scientists gather data first and then mine it for patterns — like drawing a bullseye around a bull…" 29:40 . The correct scientific workflow is: form a theory, make a specific prediction, gather data, check whether the prediction was right, and update beliefs. What has actually been happening — what Epstein calls HARKing (Hypothesizing After the Results are Known) — is more like a sharpshooter firing randomly at a wall and then drawing bullseyes around wherever the shots landed. The clinical consequence of this approach is stark: for decades leading into 2000, cardiovascular medication trials were almost uniformly positive. Then, starting in 2000, they were almost uniformly negative. Medicine had not stopped working; a funding agency had simply started requiring pre-registered predictions before trials began, and suddenly the retrospective data mining was no longer possible [2] — David Epstein "Replication crisis: most published research is false: David Epstein argues that most published research is not true because scientists gath…" 29:40 . The human face of the crisis is Brian Wansink, once the world's most famous nutrition researcher, who in a now-infamous blog post titled 'The Grad Student Who Never Says No' described instructing a student to mine datasets until she found something publishable. About 18 of his papers were retracted. Epstein links this to practical advice for individuals: in your own life, before making any significant change or testing any new approach, write down your prediction of what will happen — then test it and update slowly.
David Epstein argues that most published research is not true because scientists gather data first and then look for patterns retrospectively — like drawing a bullseye around a bullet hole — rather than committing to predictions before testing.
Most published research is wrong because scientists gather data first and then mine it for patterns — like drawing a bullseye around a bullet hole. Cardiovascular drug trials were almost all positive before 2000, then almost all negative after, not because medicine changed but because funding agencies finally required pre-registered predictions.
Brian Wansink, once the world's most famous nutrition researcher, had approximately 18 of his papers retracted after he publicly described encouraging a grad student to mine datasets for any significant result rather than testing pre-registered hypotheses.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.